SOUTH SAN FRANCISCO, CA, January 5, 2026 – Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual… The post Star Therapeutics to Present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, January 12 appeared first on STAR Therapeutics .